MindBio Therapeutics Corp. (FRA:WF60)
Germany · Delayed Price · Currency is EUR | Market Cap | 578.98K -72.5% |
| Revenue (ttm) | n/a |
| Net Income | -4.24M |
| EPS | -0.69 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1 |
| Open | 0.0815 |
| Previous Close | 0.0685 |
| Day's Range | 0.0815 - 0.0815 |
| 52-Week Range | 0.0515 - 2.0700 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 29, 2026 |
About MindBio Therapeutics
MindBio Therapeutics Corp., together with its subsidiaries, engages in researching, developing, and testing psychedelic substances as a potential treatment for the management of various mental health conditions in Australasia. Its lead drug candidate is MB22001, a form of lysergic acid diethylamide in Phase 2A trials. The company also develops wearable devices to collect biometric data in mental health patients taking psychedelic medicines; and invests in research that forms the basis for developing novel and clinically proven treatments for de... [Read more]
News
UPDATE – MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing In Preparation for First Commercial Pilot.
VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “Company” or “MindBio”), a biotechnology company advancing the ...
MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.
VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “Company” or “MindBio”), a biotechnology company advancing the ...
MindBio Completes Manufacture and Delivery of First Prototype Edge AI Intoxication and Fatigue Detection Kiosks
VANCOUVER, British Columbia, June 09, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializi...
MindBio Launches Intox AI™ in Major Advancement for Drug Use Detection
15 World firsts claimed by the Company in patent applications filed Discoveries enhance MindBio's commercialization pipeline for the detection of neurologically active substances non-invasively, using...
NetworkNews Audio Announces Audio Press Release (APR) Discussing Combining Artificial Intelligence with Speech Analysis to Detect Intoxication
AUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “The Future of Intoxication Detection May Be in Your Voice,” featuring MindBio...
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- MindBio Therapeutics Co...
IBN Announces Latest Episode of The TechMediaWire Podcast featuring Justin Hanka, CEO of MindBio Therapeutics Corp.
This news release has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising This news release has been disseminated on behalf of MindBio Therapeutics Corp. and may...
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Leveraging AI, Voice Analysis to Develop Intoxication Detection
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- MindBio Therapeutics Corp...
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
Patent application filed in World First claims. Detection of Neurologically Active Substances and Fatigue in a Human by Analysis of Voice Characteristics. Patent application filed in World First claim...
MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts using Voice and AI
VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializin...
MindBio Files Patent Applications in 15 World Firsts
15 world first discoveries transform our understanding of physiological reactions to neurologically active substances that when consumed, affect the central nervous system and speech. The prediction m...
MindBio Appoints Market Maker Venture Liquidity Providers
MindBio has appointed Venture Liquidity Providers Inc to initiate its market making service to provide assistance in maintaining an orderly trading market
MindBio Deploys New Technology Intox Collect™; Expands CNS Drug Detection Capabilities with Voice & Facial Recognition
New technology Intox Collect™ has been completed for collection and analysis of voice and facial recognition data using AI for alcohol and a range of new substances that effect the central nervous sys...
MindBio Announces Closing of Private Placement
Vancouver, British Columbia – April 1, 2026 – TheNewswire - MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF) (the “ Company ” or “ MindBio ”), a biotechnology company that is ...
MindBio Announces Upsize to Private Placement up to $1.5 Million
Vancouver, British Columbia – TheNewswire - March 19, 2026 – MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company comm...
MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation
Vancouver, British Columbia – TheNewswire - February 24, 2026 – MindBio Therapeutics Corp. (CSE: MBIO | Frankfurt: WF6 | OTCQB: MBQIF) (“MindBio” or the “Company”), a biotechnology innovator commercia...
MindBio Announces Private Placement to Raise up to $650,000
Vancouver, British Columbia - TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company t...
MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform
Vancouver, British Columbia – TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6) (OTCQB: MBQIF) (“MindBio” or the “Company”) , a biotechnology company commercial...
MindBio Deploys Engineers to South American Mining Industry, Accelerates Investment in Enterprise Voice AI Health Diagnostics.
Vancouver, British Columbia – TheNewswire - February 4, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), is pleased to report following it...
MindBio to Revolutionise Drug and Alcohol Testing in the Mining Industry using AI Voice-Based Drug & Alcohol Detection Solution
CEO Meets with Mining and Health Executives in South America to discuss deployment of new drug and alcohol screening solution. Mining deployment of the technology would disrupt drug and alcohol testi...
MindBio Targets Global Digital Health Diagnostics Market with World First AI Powered Speech Analytics Technology
Vancouver, British Columbia – TheNewswire - January 27, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that cond...
MindBio Showcases World First Voice AI Intoxication Detection Technology in USA. Targets Health Diagnostics Market with Exciting New Technology
Vancouver, British Columbia – TheNewswire - January 2 1 , 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that co...
MindBio Lists for Trading on OTCQB Market
Vancouver, British Columbia – TheNewswire - January 21, 202 6 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that con...